According to the latest report compiled by Variant Market Research, the global treatment for syndromes of dementia & movement disorders market is projected to reach $28.6 Billion by 2024, from $14.5 Billion in 2016, at a CAGR of 8.9% from 2016 to 2024.
Download Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/treatment-for-syndromes-of-dementia-and-movement-disorders-market/sample-request
Growing investments in R&D to drive the global market
The global treatment for syndromes of dementia & movement disorders market is driven by factors such as rise in geriatric population, growing knowledge and accessibility towards various healthcare services, and increasing investments in R&D. However, lack of appropriate disorder management & long approval time for drugs and devices may hamper the market growth. Furthermore, emerging economies and numerous awareness programs to increase the level of knowledge would be an opportunity in the market.
The global treatment for syndromes of dementia and movement disorders market is classified into type and geography. Type segment includes into movement disorders (Parkinson’s disease, progressive supranuclear palsy, hallervorden-spatz disease, and multiple system atrophy, among others), progressive dementia (Alzheimer’s disease, frontotemporal dementia/pick, Lewy body dementia, and others) and progressive dementia with neurological abnormality (amyotrophic lateral sclerosis(ALS), huntington’s disease, and corticobasal ganglionic degeneration). Key regions such as North America, Europe, Asia-Pacific and Rest of World (RoW) are included in the global market.
Treatment for Syndromes of Dementia and Movement Disorders Market – Get Table of Content (TOC) @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/treatment-for-syndromes-of-dementia-and-movement-disorders-market/toc
Progressive dementia by type, is estimated to dominated the global market in 2016
Progressive dementia held for the highest market share in 2016, and expected to continue its dominance over the forecast period, 2016 – 2024.
Asia-Pacific is estimated to witness fastest CAGR from 2016 to 2024
Asia-Pacific is predicted to grow at a fastest CAGR over the forecast period 2016 to 2024. The growth is attributed to large population base, and increasing healthcare facilities. The North America comprises U.S., Canada, and Mexico, whereas Germany, UK, Italy, France, Spain, and Rest of Europe are covered under the Europe. India, Japan, China, and Rest of Asia-Pacific are key sub segment of Asia-Pacific. RoW includes Middle East, South America, and Africa.
The key market players of the market are Merck & Co., Inc., AstraZeneca GmbH, Valeant Pharmaceutical International, F. Hoffmann-La Roche, AG, Abbott Laboratories, Inc., Novartis AS, Sanofi S.A., Bristol-Myers Squibb, Pfizer, Inc., and Baxter International, Inc., among others.
To browse the complete report, visit at https://www.variantmarketresearch.com/report-categories/pharmaceuticals/treatment-for-syndromes-of-dementia-and-movement-disorders-market
Scope of the Global Treatment for Syndromes of Dementia and Movement Disorders Market
- Movement Disorders
- Parkinson’s Disease
- Progressive Supranuclear Palsy
- Multiple System Atrophy
- Hallervorden-Spatz Disease
- Progressive Dementia
- Alzheimer’s Disease
- Lewy Body Dementia
- Frontotemporal Dementia/Pick
- Progressive Dementia with Neurological Abnormality (PDNA)
- Huntington’s Disease
- Corticobasal Ganglionic Degeneration
- Amyotrophic Lateral Sclerosis (ALS)
- North America
- South America
- Middle East
About Variant Market Research
Variant Market Research offers syndicated and customized reports to fulfill clients’ objectives. We also provide customized data packs proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.
For further information, visit https://www.variantmarketresearch.com
You can connect with us on LinkedIn here @ https://www.linkedin.com/company/variant-market-research
Head – Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco,
CA 94105,United States.